[go: up one dir, main page]

MX2014008336A - Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. - Google Patents

Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.

Info

Publication number
MX2014008336A
MX2014008336A MX2014008336A MX2014008336A MX2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A
Authority
MX
Mexico
Prior art keywords
antiallodynic
antihyperalgesic
pharmaceutical compositions
treating
compositions containing
Prior art date
Application number
MX2014008336A
Other languages
English (en)
Inventor
Maria Elena Garcia Armenta
Victor Guillermo Alvarez Ochoa
Original Assignee
Pptm Internat S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53938368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014008336(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pptm Internat S A R L filed Critical Pptm Internat S A R L
Priority to MX2014008336A priority Critical patent/MX2014008336A/es
Priority to PE2017000033A priority patent/PE20171140A1/es
Priority to BR112017000359-7A priority patent/BR112017000359A2/pt
Priority to PCT/IB2015/055127 priority patent/WO2016005897A1/en
Publication of MX2014008336A publication Critical patent/MX2014008336A/es
Priority to CONC2017/0001076A priority patent/CO2017001076A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una novedosa combinación farmacéutica sinérgica de un agente antihiperalgésico, antialodínico y un agente antiinflamatorio, en donde el agente antihiperalgésico, antialodínico es Pregabalina, y el agente antiinflamatorio es Meloxicam. La presente invención además está dirigida a composiciones farmacéuticas que comprenden dicha combinación, y al uso de dicha combinación y composiciones farmacéuticas para la prevención y/o tratamiento del dolor neuropático ocasionado por diversas etiologías.
MX2014008336A 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. MX2014008336A (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
PE2017000033A PE20171140A1 (es) 2014-07-07 2015-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico
BR112017000359-7A BR112017000359A2 (pt) 2014-07-07 2015-07-07 combinação de pregabalina e meloxicam para o tratamento de dor neuropática
PCT/IB2015/055127 WO2016005897A1 (en) 2014-07-07 2015-07-07 Combination of pregabalin and meloxicam for the treatment of neuropathic pain
CONC2017/0001076A CO2017001076A2 (es) 2014-07-07 2017-02-06 Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.

Publications (1)

Publication Number Publication Date
MX2014008336A true MX2014008336A (es) 2016-01-07

Family

ID=53938368

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.

Country Status (5)

Country Link
BR (1) BR112017000359A2 (es)
CO (1) CO2017001076A2 (es)
MX (1) MX2014008336A (es)
PE (1) PE20171140A1 (es)
WO (1) WO2016005897A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112353767A (zh) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3687520A4 (en) * 2017-09-28 2021-06-23 Nevakar, Inc FIXED-DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN
MX388067B (es) * 2019-07-16 2025-03-19 Federico Amezcua Amezcua Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129907A (en) 1999-08-04 2000-10-10 Colgate Palmolive Company Stable hydrogenated lupulone antibacterial oral compositions
EP1481673A4 (en) 2002-02-05 2008-09-24 Ajinomoto Kk MEDICAL COMPOSITIONS WITH GABAPENTIN OR PREGABALINE AND N-TYPE CALCIUM CHANNEL ANTAGONIST
DE10331305A1 (de) 2003-07-10 2005-02-17 Siemens Ag Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
BRPI0610316A2 (pt) 2005-05-20 2010-06-15 Pfizer Ltd combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
ES2416723T3 (es) 2007-10-09 2013-08-02 Merck Patent Gmbh Composiciones farmacéuticas que contienen benfotiamina y gabapentina
CN102908339A (zh) 2007-11-23 2013-02-06 格吕伦塔尔有限公司 他喷他多组合物
MX336979B (es) 2011-12-16 2016-02-09 Senosiain S A De C V Lab Combinacion farmaceutica antineuritica y composiciones.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112353767A (zh) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用

Also Published As

Publication number Publication date
WO2016005897A1 (en) 2016-01-14
BR112017000359A2 (pt) 2018-06-26
CO2017001076A2 (es) 2017-05-31
PE20171140A1 (es) 2017-08-09

Similar Documents

Publication Publication Date Title
MX2018003472A (es) Moduladores de la expresion de kras.
MX2019003790A (es) Analogos de isoxazol como agonistas de fxr y metodos de uso de los mismos.
ZA201701299B (en) Glycosidase inhibitors
BR112018003026A2 (pt) composições compreendendo um inibidor de pi3k e um inibidor de hdac
PH12016502062B1 (en) Compositions and methods for modulating complement factor b expression
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
UY36014A (es) ?derivado de pirazol amida, composición farmacéutica y método para tratar o prevenir enfermedades autoinmunes, inflamatorias, metabólicas o cancerosas?.
PH12019502646A1 (en) Pyrazole magl inhibitors
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
PH12017502051A1 (en) TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
PH12019502174A1 (en) Modulators of pcsk9 expression
MX2017004808A (es) Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple.
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
EA201791174A1 (ru) Антимикотическое соединение
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
TN2018000057A1 (en) Compounds useful for inhibiting ror-gamma-t.
EA201692020A1 (ru) Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях
MX2017004819A (es) Metodos de tratamiento de transtornos urológicos usando sarm.
MX2014008336A (es) Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
PH12017501897A1 (en) 2-thiopyrimidinones
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
EP3881845A3 (en) Combination of trazodone and gabapentin for the treatment of pain